The Pharmacist & Patient-Centered Diabetes Care

APhA's “The Pharmacist and Patient-Centered Diabetes Care” Certificate Training Program was the recipient of the 2015 Award, Alliance for Continuing Education in the Health Professions’,  for outstanding Live CE Activity. This award recognizes an organization for innovation and excellence in the design, educational format, and instructional delivery of a live CE activity or educational initiative.



Activity Preview

The American Pharmacists Association (APhA) developed The Pharmacist and Patient-Centered Diabetes Care Certificate Training Program, is an educational experience designed to equip pharmacists with the knowledge, skills, and confidence needed to provide effective, evidence-based diabetes care. The program provides comprehensive instruction in current diabetes concepts and standards of care and incorporates case studies and hands-on skills training focused on the situations most likely to be encountered—as well as the services most needed—in community and ambulatory care practice settings. Participants will gain experience evaluating and adjusting drug therapy regimens for patients with type 1 and type 2 diabetes, counseling patients about lifestyle interventions, analyzing and interpreting self-monitoring of blood glucose results, and assessing the overall health status of patients to identify needed monitoring and interventions.

Activity Type: Application and Practice-based
Target Audience: Pharmacists in all practice settings
Learning Level: Level 3

Goals and Learning Objectives

The goal of The Pharmacist and Patient-Centered Diabetes Care is to teach the pharmacist how to integrate diabetes education and management into practice. This overriding goal incorporates the goal of pharmaceutical care, which is to ensure that patients make the best use of their medications and achieve the desired therapeutic outcomes. Specific program goals are to: 

  • Provide comprehensive instruction on current standards of care for patients with diabetes.
  • Increase pharmacists’ ability to apply pharmacotherapeutic information and serve as the drug therapy expert on the diabetes health care team.
  • Refresh pharmacists’ knowledge of the pathophysiology of diabetes and the acute and long‐term complications of the disease.
  • Familiarize pharmacists with important concepts in nutrition, exercise, and weight control that contribute to optimal diabetes care.
  • Provide training on the use of diabetes-related devices and physical assessments involved with optimal diabetes care.
  • Describe business opportunities and roles for pharmacists in improving health outcomes for patients with diabetes.

This ACPE activity does not provide a certification in this topic but rather advanced professional training which upon successful completion the learner will be able to download a certificate of achievement.

Self-Study Learning Objectives

Module 1. Pathogenesis and Diagnosis of Diabetes

At the completion of this activity, participants will be able to:

  • Explain important concepts in glucose homeostasis.
  • Describe the pathophysiology and clinical manifestations of type 1 diabetes and type 2 diabetes.
  • List diagnostic criteria and the treatment goals for patients with diabetes.
  • Describe the implications of cardiorenal metabolic syndrome and obesity in patients with diabetes.

Module 2. Monitoring Glucose Levels

At the completion of this activity, participants will be able to:

  • Describe outcomes-based evidence related to glycemic control in patients with type 1 or type 2 diabetes.
  • Explain strategies for managing hypoglycemia.

Module 3. Goals of Care and Approaches to Nonpharmacologic Management

At the completion of this activity, participants will be able to:

  • Discuss basic concepts of carbohydrate counting and meal planning for patients with diabetes.
  • Identify best practices for lifestyle management in patients with diabetes.

Module 4. Pharmacotherapy of Diabetes

At the completion of this activity, participants will be able to:

  • Describe antidiabetic agents according to their primary mechanism of action, efficacy for various outcomes, principal adverse effects, and appropriate clinical use.
  • Explain currently recommended pharmacologic approaches for managing type 1 and type 2 diabetes. Identify medications that impact cardiorenal outcomes.

Module 5. Managing Comorbidities

At the completion of this activity, participants will be able to:

  • Identify screening and treatment recommendations for comorbidities commonly associated with type 1 and type 2 diabetes, including autoimmune diseases, non-alcoholic fatty liver disease, nephropathy, retinopathy, and gastroparesis.

Module 6. The Pharmacist’s Role in Diabetes Self-Management Education and Support

At the completion of this activity, participants will be able to:

  • Explain how pharmacists can obtain recognized diabetes care credentials.
  • Describe the value of obtaining advanced diabetes care credentials.
Seminar Learning Objectives

At the completion of this activity, the participant will be able to:

  • Apply key concepts of diabetes care, including selection of appropriate treatment approaches, to patient cases.
  • Demonstrate effective communication strategies for educating patients with diabetes to manage their condition.
  • Demonstrate how to perform a fingerstick for assessing blood glucose levels and inject medications with syringes or pens.
  • Discuss the clinical value of CGM for patients living with diabetes
  • Evaluate data from various blood glucose logs, including those generated by continuous glucose monitoring.
Accreditation Information 

The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The Pharmacist and Patient-Centered Diabetes Care certificate training program is approved for a total of 8 contact hours of continuing pharmacy education (CPE) credit (0.8 CEUs). The ACPE Universal Activity Numbers (UAN) for this activity are listed below.

  • Successful completion of the self-study component involves passing the self-study assessment with a grade of 70% or higher and will result in 4 contact hours of CPE credit (0.4 CEUs). ACPE UAN: 0202-0000-23-436-H01-P
  • Successful completion of the live seminar component involves attending the full live seminar, successfully demonstrate competency in the utilization and/or evaluation of these devices, and completing the online assessment and evaluation. Successful completion of this component will result in 4 contact hours of CPE credit (0.4 CEU). ACPE UAN: 0202-0000-23-437-L01-P / 0202-9999-23-437-L01-P

To obtain 8 contact hours of CPE credit (0.8 CEUs) for APhA's The Pharmacist and Patient-Centered Diabetes Care certificate training program, the learner must complete all components listed above, and CLAIM credit for each component. Participants will need to have a valid APhA ( username and password, as well as a CPE Monitor account to claim credit. After credit has been claimed, please visit CPE monitor for your transcript. The Certificate of Achievement will be available online upon successful completion of the necessary activity requirements on the participant’s My Training page on

APhA continuing pharmacy education policy provides you with two opportunities to successfully complete the continuing pharmacy education assessment. Please note that you will not be permitted to submit the assessment a third time. The current policy of the APhA Education Department is not to release the correct answers to any of our CPE tests. This policy is intended to maintain the integrity of the CPE activity and the assessment.

Release Date:  December 20, 2023

Expiration Date: December 20, 2026 - PLEASE NOTE: NO Home Study credit granted after this date; Live Credit can only be granted within 60 days from the day of the seminar attended.


The Pharmacist and Patient-Centered Diabetes Care was developed by the American Pharmacists Association.  Copyright © 2024 by the American Pharmacists Association.

Acknowledgements and Disclosures
Advisory Board
  • Susan Cornell, PharmD, CDCES, FAPhA, FADCES, Associate Director of Experiential Education, Professor, Pharmacy Practice; Midwestern University College of Pharmacy; Downers Grove, Illinois
  • Staci-Marie Norman, PharmD, CDE, Clinical Coordinator and Manager, Martin’s Pharmacy, South Bend, Indiana
  • Jennifer D. Smith, PharmD, CPP, BC-ADM, CDCES, FAPhA, Clinical Pharmacy Specialist in an Outpatient Center, U.S. Department of Veterans Affairs; Upstate South Carolina
APhA Staff Members

The following APhA staff members contributed to the development of this program:

  • Katie Meyer, PharmD, BCPS, BCGP, Director, Content Creation
  • Bronhed Shaw, Associate Director, Advanced Training

The original publication was prepared by Judy Crespi Lofton, MS, of JCL Communications, on behalf of APhA.

  • Susan Cornell, PharmD, CDCES, FAPhA, FADCES serves as a speaker and advisory board member for Novo Nordisk for which she has received an honorarium.
  • Staci-Marie Norman, PharmD, CDE, declares her spouse is a sales representative for Takeda Pharmaceuticals.
  • All other individuals involved in the development of this material declare no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria.  
  • Conflicts of interest have been resolved through content review by Katie Meyer, PharmD, BCPS, BCGP, Director of Content Creation at the American Pharmacists Association. 
  • The material presented here does not necessarily reflect the views of the American Pharmacists Association. Every attempt has been made to ensure the accuracy of the information contained herein at the time of writing; however, owing to the nature of pharmacy practice, standards and recommendations change regularly. Pharmacists are advised to verify all information and data before treating patients or employing the practices described in this educational activity.